Thursday, May 08, 2008

Statement issued on DTC hearing

From the article:
Stupak delivered the following statement:

Nearly 10 years ago, the U.S. Food and Drug Administration (FDA) relaxed its rules related to direct-to-consumer (DTC) advertisements for prescription pharmaceutical products.

Since then, spending on DTC ads has increased from about $1.1 billion in 1997 to about $4.2 billion in 2005.

This nearly 300 percent increase in DTC ad spending dwarfs the 86 percent spending increase in advertisements to physicians and the 103 percent spending increase in research and development over the same period.
Click here to read the entire statement (and article). I say we blame it all on Joan Lunden.

No comments: